Comparable outcomes between Besifovir and other antiviral therapies in hepatocellular carcinoma development among patients with chronic hepatitis B

被引：0
|
作者：
Lee, Jae Seung [1 ]
Lee, Won [2 ]
Kim, Sang Gyune [3 ]
Seo, Yeon Seok [4 ]
Yu, Su Jong [5 ,6 ]
Yim, Hyung Joon [7 ]
Lee, Hye Won [1 ]
Kim, Mi Na [1 ]
Kim, Beom Kyung [1 ]
Park, Jun Yong [1 ]
Kim, Do Young [1 ]
Ahn, Sang Hoon [1 ]
Kim, Seung Up [1 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Internal Med, Sch Med, Bucheon, South Korea
[3] Soonchunhyang Univ, Coll Med, Dept Internal Med, Bucheon Hosp, Bucheon, South Korea
[4] Korea Univ, Coll Med, Dept Internal Med, Anam Hosp, Seoul, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea
[7] Korea Univ, Coll Med, Div Gastroenterol & Hepatol, Dept Internal Med,Ansan Hosp, Ansan, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-404
引用
收藏
页码：S799 / S799
页数：1
相关论文
共 50 条
  • [1] COMPARABLE OUTCOMES BETWEEN BESIFOVIR AND OTHER ANTIVIRAL THERAPIES IN HEPATOCELLULAR CARCINOMA DEVELOPMENT AMONG PATIENTS WITH CHRONIC HEPATITIS B
    Lee, Jae Seung
    Lee, Sung Won
    Kim, Sang Gyune
    Seo, Yeon Seok
    Yu, Su Jong
    Yim, Hyung Joon
    Lee, Hye Won
    Kim, Mi Na
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY, 2024, 80 : S293 - S294
  • [2] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR
    Yim, Hyung Joon
    Kang, Seong Hee
    Jung, Young Kul
    Ahn, Sang Hoon
    Kim, Won
    Yang, Jin Mo
    Jang, Jae Young
    Cho, Yong Kyun
    Kim, Yoon Jun
    Kim, Dong Joon
    Kweon, Young-Oh
    Hong, Gun Young
    Sohn, Joo Hyun
    Lee, Jin-Woo
    Park, Sung Jae
    Young, Yim Sun
    Shin, Seung Kak
    Kim, Ji Hoon
    Seo, Yeon Seok
    Park, Jin Kyung
    Um, Soonho
    HEPATOLOGY, 2023, 78 : S1828 - S1829
  • [3] Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B
    Koklu, Seyfettin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (01): : 124 - 124
  • [4] Can antiviral therapy in patients with chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Vasilieva, L.
    Dourakis, S. P.
    ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (05): : 566 - 575
  • [5] Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
    Vlachogiannakos, John
    Papatheodoridis, George
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (47) : 8822 - 8830
  • [6] Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
    John Vlachogiannakos
    George Papatheodoridis
    World Journal of Gastroenterology, 2013, (47) : 8822 - 8830
  • [7] Monitoring the effect of antiviral treatment on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients
    Mert, Kamil
    Tatar, Bengu
    Nadir, Yasemin
    Senger, Suheyla Serin
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (12):
  • [8] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    HEPATOLOGY, 2023, 78 : S491 - S492
  • [9] Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
    Kim, Sung Eun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (04): : 631 - 633
  • [10] Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Thursz, Mark
    Brown, Ashley
    GUT, 2011, 60 (08) : 1025 - 1026
12345